In addition, injection of iohexol causes more marked increase in CD31+/CD41a− EMPs and PMPs in patients with DM than in those without DM, indicating that diabetic patients are more sensitive to iohexol. This evidence concerns the gene PECAM1 and diabetes mellitus.